Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Phospho-ATF2 (Thr71) Mouse anti-Human, Clone: 103C411.2, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA141116

Catalog No. 01-676-470


Add to cart

Description

Description

Suggested positive control: TNF-a treated HeLa (1 hr).

ATF-2 is a member of the group of bZip transcription factors. Heterodimer formation between members of the bZip group is common and is believed to add diversity to the cis-acting elements at which binding of the dimers is directed. Specifically, ATF-2 may dimerize with c-Jun, as occurs in response to E1a, and in so doing shift the binding preference of c-Jun toward ATF/CRE sites (1-3). Deletion analysis has indicated that the N-terminal region of ATF-2 containing threonine at residues 69 and 71 are essential for this purpose. These threonine residues are phosphorylated by JNK/SAPK for transcriptional activation.
Specifications

Specifications

Phospho-ATF2 (Thr71)
Monoclonal
0.5 mg/mL
PBS with 0.05% BSA and 0.05% sodium azide
P15336
CRE-BP1, CREB2, HB16, MGC111558, TREB7
Mouse
IgG1
100 μg
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Primary
1386
Flow Cytometry, Western Blot
103C411.2
Unconjugated
ATF2
Liquid
ATF2
Synthetic phosphopeptide coorresponding to the residues surrounding phosphorylation site 71 of human ATF-2.
Protein G
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit